Targeted delivery of platinum-based anticancer complexes

Current Opinion in Chemical Biology

Volumn 17, Issue 2, 2013, Pages 175-188

  Butler, Jennifer S ^a   Sadler, Peter J ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON NANOTUBE; CARBOPLATIN; CISPLATIN; EPIDERMAL GROWTH FACTOR; FERRIC FERROCYANIDE; GOLD NANOPARTICLE; HEPARIN; LIPOSOME; OXALIPLATIN; POLYMER; PRODRUG; SOMATOSTATIN; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; TRASTUZUMAB;

ANTINEOPLASTIC ACTIVITY; BIODEGRADABILITY; DRUG DELIVERY SYSTEM; HUMAN; IC 50; LIGHT; MICELLE; PHOTOACTIVATION; REVIEW;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; HUMANS; MCF-7 CELLS; NANOSTRUCTURES; NEOPLASMS; ORGANOPLATINUM COMPOUNDS;

EID: 84876706885     PISSN: 13675931     EISSN: 18790402     Source Type: Journal    
DOI: 10.1016/j.cbpa.2013.01.004     Document Type: Review

References (64)

1. Reedijk J. Metal-ligand exchange kinetics in platinum and ruthenium complexes. Platinum Met Rev 2008, 52:2.
2. Wheate N.J., Walker S., Craig G.E., Oun R. The status of platinum anticancer drugs in the clinic and in clinical trials. Dalton Trans 2010, 39:8113-8127.
3. Wang X., Guo Z. Targeting and delivery of platinum-based anticancer drugs. Chem Soc Rev 2013, 42:202-224.
4. Ghosh Chaudhuri R., Paria S. Core/shell nanoparticles: classes, properties, synthesis, mechanisms, characterization, and applications. Chem Rev 2012, 112:2373-2443.
5. Bottini M., Rosato N., Bottini N. PEG-modified carbon nanotubes in biomedicine: current status and challenges ahead. Biomacromolecules 2011, 12:3381-3393.
6. Bianco A., Kostarelos K., Prato M. Making carbon nanotubes biocompatible and biodegradable. Chem Commun 2011, 47:10182-10188.
7. Allen B.L., Kotchey G.P., Chen Y., Yanamala N.V.K., Klein-Seetharaman J., Kagan V.E., Star A. Mechanistic investigations of horseradish peroxidase-catalyzed degradation of single-walled carbon nanotubes. J Am Chem Soc 2009, 131:17194-17205.
8. Tripisciano C., Kraemer K., Taylor A., Borowiak-Palen E. Single-wall carbon nanotubes based anticancer drug delivery system. Chem Phys Lett 2009, 478:200-205.
9. Li J., Yap S.Q., Yoong S.L., Nayak T.R., Chandra G.W., Ang W.H., Panczyk T., Ramaprabhu S., Vashist S.K., Sheu F.-S., et al. Carbon nanotube bottles for incorporation, release and enhanced cytotoxic effect of cisplatin. Carbon 2012, 50:1625-1634.
10. Guven A., Rusakova I.A., Lewis M.T., Wilson L.J. Cisplatin at US-tube carbon nanocapsules for enhanced chemotherapeutic delivery. Biomaterials 2012, 33:1455-1461.
11. Li J., Yap S.Q., Chin C.F., Tian Q., Yoong S.L., Pastorin G., Ang W.H. Platinum(iv) prodrugs entrapped within multiwalled carbon nanotubes: selective release by chemical reduction and hydrophobicity reversal. Chem Sci 2012, 3:2083-2087.
12. Ajima K., Murakami T., Mizoguchi Y., Tsuchida K., Ichihashi T., Iijima S., Yudasaka M. Enhancement of in vivo anticancer effects of cisplatin by incorporation inside single-wall carbon nanohorns. ACS Nano 2008, 2:2057-2064.
13. Dhar S., Daniel W.L., Giljohann D.A., Mirkin C.A., Lippard S.J. Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads. J Am Chem Soc 2009, 131:14652-14653.
14. Min Y., Mao C., Xu D., Wang J., Liu Y. Gold nanorods for platinum based prodrug delivery. Chem Commun 2010, 46:8424-8426.
15. Brown S.D., Nativo P., Smith J.-A., Stirling D., Edwards P.R., Venugopal B., Flint D.J., Plumb J.A., Graham D., Wheate N.J. Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin. J Am Chem Soc 2010, 132:4678-4684.
16. Huang H.-C., Barua S., Sharma G., Dey S.K., Rege K. Inorganic nanoparticles for cancer imaging and therapy. J Control Release 2011, 155:344-357.
17. Lian H.-Y., Hu M., Liu C.-H., Yamauchi Y., Wu K.C.W. Highly biocompatible, hollow coordination polymer nanoparticles as cisplatin carriers for efficient intracellular drug delivery. Chem Commun 2012, 48:5151-5153.
18. Likhitkar S., Bajpai A.K. Magnetically controlled release of cisplatin from superparamagnetic starch nanoparticles. Carbohydr Polym 2012, 87:300-308.
19. Xing R., Wang X., Zhang C., Wang J., Zhang Y., Song Y., Guo Z. Superparamagnetic magnetite nanocrystal clusters as potential magnetic carriers for the delivery of platinum anticancer drugs. J Mater Chem 2011, 21:11142-11149.
20. Dutta R.K., Sahu S. Development of oxaliplatin encapsulated in magnetic nanocarriers of pectin as a potential targeted drug delivery for cancer therapy. Results Pharma Sci 2012, 2:38-45.
21. Xiong Y., Jiang W., Shen Y., Li H., Sun C., Ouahab A., Tu J. A poly(γ,l-glutamic acid)-citric acid based nanoconjugate for cisplatin delivery. Biomaterials 2012, 33:7182-7193.
22. Rout S.R., Behera B., Maiti T.K., Mohapatra S. Multifunctional magnetic calcium phosphate nanoparticles for targeted platin delivery. Dalton Trans 2012, 41:10777-10783.
23. Chen H., Pazicni S., Krett N.L., Ahn R.W., Penner-Hahn J.E., Rosen S.T., O'Halloran T.V. Coencapsulation of arsenic-and platinum-based drugs for targeted cancer treatment. Angew Chem Int Ed 2009, 48:9295-9299.
24. Nukolova N.V., Oberoi H.S., Cohen S.M., Kabanov A.V., Bronich T.K. Folate-decorated nanogels for targeted therapy of ovarian cancer. Biomaterials 2011, 32:5417-5426.
25. Chaudhury A., Das S., Bunte R.M., Chiu G.N. Potent therapeutic activity of folate receptor-targeted liposomal carboplatin in the localized treatment of intraperitoneally grown human ovarian tumor xenograft. Int J Nanomed 2012, 7:739-751.
26. Bhirde A.A., Patel V., Gavard J., Zhang G., Sousa A.A., Masedunskas A., Leapman R.D., Weigert R., Gutkind J.S., Rusling J.F. Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery. ACS Nano 2009, 3:307-316.
27. Tseng C.L., Su W.Y., Yen K.C., Yang K.C., Lin F.H. The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation. Biomaterials 2009, 30:3476-3485.
28. Peng X.-H., Wang Y., Huang D., Wang Y., Shin H.J., Chen Z., Spewak M.B., Mao H., Wang X., Wang Y., et al. Targeted delivery of cisplatin to lung cancer using ScFvEGFR-heparin-cisplatin nanoparticles. ACS Nano 2011, 5:9480-9493.
29. 4 nanoparticles for target-specific platin delivery. J Am Chem Soc 2009, 131:4216-4217.
30. Krieger M.L., Eckstein N., Schneider V., Koch M., Royer H.-D., Jaehde U., Bendas G. Overcoming cisplatin resistance of ovarian cancer cells by targeted liposomes in vitro. Int J Pharm 2010, 389:10-17.
31. Sankhala K.K., Mita A.C., Adinin R., Wood L., Beeram M., Bullock S., Yamagata N., Matsuno K., Fujisawa T., Phan A. A phase I pharmacokinetic (PK) study of MBP-426, a novel liposome encapsulated oxaliplatin. ASCO Meeting Abstracts 2009, 27:2535.
32. Winer I., Wang S., Lee Y-EK, Fan W., Gong Y., Burgos-Ojeda D., Spahlinger G., Kopelman R., Buckanovich R.J. F3-targeted cisplatin-hydrogel nanoparticles as an effective therapeutic that targets both murine and human ovarian tumor endothelial cells in vivo. Cancer Res 2010, 70:8674-8683.
33. Graf N., Mokhtari T.E., Papayannopoulos I.A., Lippard S.J. Platinum(IV)-chlorotoxin (CTX) conjugates for targeting cancer cells. J Inorg Biochem 2012, 58-63.
34. Margiotta N., Denora N., Ostuni R., Laquintana V., Anderson A., Johnson S.W., Trapani G., Natile G. Platinum(II) complexes with bioactive carrier ligands having high affinity for the translocator protein. J Med Chem 2010, 53:5144-5154.
35. Ndinguri M.W., Solipuram R., Gambrell R.P., Aggarwal S., Hammer R.P. Peptide targeting of platinum anti-cancer drugs. Bioconjug Chem 2009, 20:1869-1878.
36. Gaviglio L., Gross A., Metzler-Nolte N., Ravera M. Synthesis and in vitro cytotoxicity of cis,cis,trans-diamminedichloridodisuccinatoplatinum(iv)-peptide bioconjugates. Metallomics 2012, 4:260-266.
37. Abramkin S., Valiahdi S.M., Jakupec M.A., Galanski M., Metzler-Nolte N., Keppler B.K. Solid-phase synthesis of oxaliplatin-TAT peptide bioconjugates. Dalton Trans 2012, 41:3001-3005.
38. Graf N., Bielenberg D.R., Kolishetti N., Muus C., Banyard J., Farokhzad O.C., Lippard S.J. αVβ3 integrin-targeted PLGA-PEG nanoparticles for enhanced anti-tumor efficacy of a Pt(IV) prodrug. ACS Nano 2012, 6:4530-4539.
39. Dhar S., Lippard S.J. Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate. Proc Natl Acad Sci U S A 2009, 106:22199-22204.
40. Stathopoulos G.P., Rigatos S., Stathopoulos J., Batzios S. Liposomal cisplatin in cancer patients with renal failure. J Drug Deliv Ther 2012, 2:106-109.
41. Dhar S., Kolishetti N., Lippard S.J., Farokhzad O.C. Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo. Proc Natl Acad Sci U S A 2011, 108:1850-1855.
42. Huxley M., Sanchez-Cano C., Browning M.J., Navarro-Ranninger C., Quiroga A.G., Rodger A., Hannon M.J. An androgenic steroid delivery vector that imparts activity to a non-conventional platinum(II) metallo-drug. Dalton Trans 2010, 39:11353-11364.
43. Ruiz-Sánchez P., König C., Ferrari S., Alberto R. Vitamin B12 as a carrier for targeted platinum delivery: in vitro cytotoxicity and mechanistic studies. J Biol Inorg Chem 2011, 16:33-44.
44. Nowotnik D.P., Cvitkovic E. ProLindac™ (AP5346): a review of the development of an HPMA DACH platinum polymer therapeutic. Adv Drug Deliv Rev 2009, 61:1214-1219.
45. Duan S., Cai S., Xie Y., Bagby T., Ren S., Forrest M.L. Synthesis and characterization of a multiarm poly(acrylic acid) star polymer for application in sustained delivery of cisplatin and a nitric oxide prodrug. J Polym Sci A: Polym Chem 2012, 50:2715-2724.
46. Yang J., Mao W., Sui M., Tang J., Shen Y. Platinum(IV)-coordinate polymers for cancer drug delivery. J Control Release 2011, 152:e108-e109.
47. Aryal S., Hu C-MJ, Zhang L. Polymer-cisplatin conjugate nanoparticles for acid-responsive drug delivery. ACS Nano 2010, 4:251-258.
48. Vieira D.B., Kim V., Petri D.F.S., Menck C.F.M., Carmona-Ribeiro A.M. Polymer-based delivery vehicle for cisplatin. Nanotechnology 2011: Bio Sensors, Instruments, Medical, Environment and Energy 2011, 382-385. CRC Press. NSTI (Ed.).
49. Xiao H., Fan Y., Liu S., Chen X., Huang Y., Jing X. New polymer-platinum(II) antitumor conjugates. J Control Release 2011, 152:e103-e104.
50. Duong H.T.T., Huynh V.T., de Souza P., Stenzel M.H. Core-cross-linked micelles synthesized by clicking bifunctional Pt(IV) anticancer drugs to isocyanates. Biomacromolecules 2010, 11:2290-2299.
51. Huynh V.T., de Souza P., Stenzel M.H. Polymeric micelles with pendant dicarboxylato chelating ligands prepared via a Michael addition for cis-platinum drug delivery. Macromolecules 2011, 44:7888-7900.
52. Huynh V.T., Quek J.Y., de Souza P.L., Stenzel M.H. Block copolymer micelles with pendant bifunctional chelator for platinum drugs: effect of spacer length on the viability of tumor cells. Biomacromolecules 2012, 13:1010-1023.
53. Matsumura Y., Kataoka K. Preclinical and clinical studies of anticancer agent-incorporating polymer micelles. Cancer Sci 2009, 100:572-579.
54. Xue Y., Tang X., Huang J., Zhang X., Yu J., Zhang Y., Gui S. Anti-tumor efficacy of polymer-platinum(II) complex micelles fabricated from folate conjugated PEG-graft-α,β-poly [(N-amino acidyl)-aspartamide] and cis-dichlorodiammine platinum(II) in tumor-bearing mice. Colloids Surf B: Biointerfaces 2011, 85:280-288.
55. Haririan I., Alavidjeh M.S., Khorramizadeh M.R., Ardestani M.S., Ghane Z.Z., Namazi H. Anionic linear-globular dendrimer-cis-platinum(II) conjugates promote cytotoxicity in vitro against different cancer cell lines. Int J Nanomed 2010, 5:63-75.
56. Yano S., Hirohara S., Obata M., Hagiya Y., Ogura S.-i, Ikeda A., Kataoka H., Tanaka M., Joh T. Current states and future views in photodynamic therapy. J Photochem Photobiol C 2011, 12:46-67.
57. 2]: insights from DFT calculations. Phys Chem Chem Phys 2009, 11:10311-10316.
58. Farrer N.J., Woods J.A., Munk V.P., Mackay F.S., Sadler P.J. Photocytotoxic trans-diam(m)ine platinum(IV) diazido complexes more potent than their cis isomers. Chem Res Toxicol 2009, 23:413-421.
59. Farrer N.J., Woods J.A., Salassa L., Zhao Y., Robinson K.S., Clarkson G., Mackay F.S., Sadler P.J. A potent trans-diimine platinum anticancer complex photoactivated by visible light. Angew Chem Int Ed 2010, 49:8905-8908.
60. Zhao Y., Roberts G.M., Greenough S.E., Farrer N.J., Paterson M.J., Powell W.H., Stavros V.G., Sadler P.J. Two-photon-activated ligand exchange in platinum(II) complexes. Angew Chem Int Ed 2012, 51:11263-11266.
61. 3)]: a light activated antitumor platinum complex that kills human cancer cells by an apoptosis independent mechanism. Mol Cancer Ther 2012, 11:1894-1904.
62. Butler J.S., Woods J.A., Farrer N.J., Newton M.E., Sadler P.J. Tryptophan switch for a photoactivated platinum anticancer complex. J Am Chem Soc 2012, 134:16508-16511.
63. Pracharova J., Zerzankova L., Stepankova J., Novakova O., Farrer N.J., Sadler P.J., Brabec V., Kasparkova J. Interactions of DNA with a new platinum(IV) azide dipyridine complex activated by UVA and visible light: relationship to toxicity in tumor cells. Chem Res Toxicol 2012, 25:1099-1111.
64. Mlcouskova J., Stepankova J., Brabec V. Antitumor carboplatin is more toxic in tumor cells when photoactivated: enhanced DNA binding. J Biol Inorg Chem 2012, 17:891-898.